Cellulitis - Selulitishttps://en.wikipedia.org/wiki/Cellulitis
Selulitis (Cellulitis) nyaéta inféksi baktéri anu ngalibatkeun lapisan jero kulit. Tanda jeung gejalana nyaéta nyeri, beureum, sarta pembengkakan anu beuki gedé salila sababaraha poé. Daérah anu kemerahan umumna teu bisa dibédakeun ti kulit séjén, sarta kulitna tiasa ngagurilap. Wewengkon inféksi biasana nyeri. Sababaraha jalma tiasa ngalaman demam jeung myalgia.

Suku jeung raray nyaéta situs anu paling umum. Faktor résiko kalebet obesitas, suku anu baréah, jeung umur sepuh. Baktéri anu paling sering kalibet nyaéta streptococci jeung Staphylococcus aureus.

Pangobatan biasana ngagunakeun antibiotik oral, sapertos cephalexin, amoxicillin, atawa cloxacillin. Sakitar 95 % pasien cageur sanggeus 7–10 poé pangobatan. Pasien anu ngidap diabetes, kumaha ogé, sering boga hasil anu leuwih parah.

Selulitis mangrupikeun gangguan umum, sarta di Inggris, selulitis nyumbang 1,6 % tina sadaya rawat inap rumah sakit. Dina 2015, cellulitis nyababkeun kira-kira 16 900 maot di dunya.

○ Perlakuan – Obat OTC
Selulitis anu parah merlukeun antibiotik resep ti dokter. Lamun lesi maju gancang sarta dibarengan ku demam jeung menggigil, penting pikeun gancang ningali dokter.
Nerapkeun salep antibiotik over‑the‑counter kana lesi awal bisa mantuan. Upami salep dipaké teuing ipis, éta moal efektif.
#Polysporin
#Bacitracin
#Betadine

Paké analgesik OTC sapertos acetaminophen pikeun ngurangan nyeri.
#Ibuprofen
#Naproxen
#Acetaminophen

Jaga suku tetep bersih jeung rawat suku atlit sabab suku atlit ningkatkeun résiko selulitis.

○ Perlakuan
#First-generation cephalosporins (e.g. Cefradine)
#Bacterial culture
#Third-generation cephalosporins (e.g. Cefditoren Pivoxil)
☆ AI Dermatology — Free Service
Dina hasil Stiftung Warentest 2022 ti Jerman, kapuasan konsumen sareng ModelDerm ngan ukur langkung handap tibatan konsultasi telemedicine anu mayar.
  • Suku nyaéta lokasi umum pikeun Selulitis (Cellulitis).
  • Kasus biasa.
  • Selulitis (Cellulitis) – Tahap Penyembuhan
  • Cellulitis dina suku kénca. Upami éta nyebar sacara lega, inféksi sistemik tiasa kajadian, nyababkeun septic shock (shock septic) anu ngancam kahirupan.
  • Nalika lesi ningkat, hyperpigmentation pos‑radang bisa muncul.
  • Ieu tiasa disababkeun ku tatu dina lontar.
  • Kasus biasa.
  • Lamun aya bercak kemerahan anu lemes sumebar gancang, Selulitis (Cellulitis) kudu dipikiran.
  • Lamun Selulitis (Cellulitis) ningkat, sél kulit paéh bisa mati, sarta bisa jadi gatel.
  • Kalolobaan kasus Selulitis (Cellulitis) dipirig ku bengkak jeung erythema di wewengkon sabudeureun. Nanging, dina kasus anu luar biasa ieu, dimana henteu aya erythema di sakurilingna, karsinoma sél skuamosa ogé kedah dipertimbangkeun.
  • Kasus ieu
  • Tahap penyembuhan.
References Cellulitis 31747177 
NIH
Cellulitis nyaéta inféksi kulit baktéri umum. Éta mangaruhan langkung ti 14 juta jalma unggal taun di Amérika Serikat. Éta nyababkeun sakitar $3.7 milyar dina biaya perawatan ambulatory sareng 650 000 rawat inap unggal taun. Ilaharna, cellulitis muncul salaku wewengkon beureum jeung haneut dina kulit, bareuh, sarta tenderness. Éta disababkeun ku inféksi baktéri ngadadak anu memicu peradangan dina lapisan kulit jero jeung jaringan caketna. Inféksi ieu henteu disertai bisul atawa nanah. Streptococci béta‑hemolytic, utamana grup A streptococcus (Streptococcus pyogenes), nyaéta panyebab umum, dituturkeun ku methicillin‑sensitive Staphylococcus aureus.
Cellulitis is a common bacterial skin infection, with over 14 million cases occurring in the United States annually. It accounts for approximately 3.7 billion dollars in ambulatory care costs and 650000 hospitalizations annually. Cellulitis typically presents as a poorly demarcated, warm, erythematous area with associated edema and tenderness to palpation. It is an acute bacterial infection causing inflammation of the deep dermis and surrounding subcutaneous tissue. The infection is without an abscess or purulent discharge. Beta-hemolytic streptococci typically cause cellulitis, generally group A streptococcus (i.e., Streptococcus pyogenes), followed by methicillin-sensitive Staphylococcus aureus. Patients who are immunocompromised, colonized with methicillin-resistant Staphylococcus aureus, bitten by animals, or have comorbidities such as diabetes mellitus may become infected with other bacteria.
 Cellulitis: current insights into pathophysiology and clinical management 29219814
Cellulitis mangrupikeun inféksi baktéri dina kulit sareng jaringan lemes. Éta kajadian nalika aya masalah dina lapisan pelindung kulit, sistem imun, atanapi sirkulasi getih. Diabetes, obesitas, sareng umur lanjut ningkatkeun risiko cellulitis ku mangaruhan daérah ieu. Urang ogé ningali papanggihan panganyarna dina diagnosis cellulitis, kalayan panyorot pentingna diagnosis anu akurat sabab kaayaan sapertos insufficiency venous, éksim, deep vein thrombosis, sarta asam urat sering bingung jeung cellulitis. Antibiotik anu dianggo pikeun ngubaran cellulitis dipilih sacara saksama pikeun nargétkeun baktéri umum tanpa ngadorong résistansi antibiotik. Urang ogé ngabahas antibiotik anyar anu disatujuan pikeun cellulitis. Cellulitis sering datang deui kusabab faktor résiko sareng karusakan sistem limfatik.
Cellulitis is a bacterial infection of the skin and soft tissues. It happens when there are issues with the skin's protective barrier, the immune system, or blood circulation. Diabetes, obesity, and old age increase the chances of cellulitis by affecting these areas. We also look at recent findings on diagnosing cellulitis, highlighting the importance of accurate diagnosis since conditions like venous insufficiency, eczema, deep vein thrombosis, and gout are often confused with cellulitis. Antibiotics used to treat cellulitis are chosen carefully to target common bacteria without encouraging antibiotic resistance. We also talk about new antibiotics approved for cellulitis. Cellulitis often comes back because of ongoing risk factors and damage to the lymphatic system..
 Current Treatment Options for Acute Skin and Skin-structure Infections 30957166 
NIH
Seueur jalma nu datang ka rumah sakit atawa kamar darurat kusabab inféksi kulit ku baktéri anu muncul sacara tiba‑tiba. Staphylococcus aureus nyaéta baktéri utama nu nyababkeun inféksi ieu, sarta jadi leuwih hésé diubaran alatan sababaraha galurna geus tahan kana antibiotik umum.
Acute bacterial skin and skin-structure infections are a common reason for seeking care at acute healthcare facilities, including emergency departments. Staphylococcus aureus is the most common organism associated with these infections, and the emergence of community-associated methicillin-resistant Staphylococcus aureus (MRSA) has represented a considerable challenge in their treatment.
 Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus 32257966 
NIH
Staphylococcus aureus bisa dibagi jadi dua jinis dumasar kana résponna kana antibiotik: methicillin-sensitive Staphylococcus aureus (MSSA), methicillin-resistant Staphylococcus aureus (MRSA). Dina sababaraha dasawarsa katukang, kusabab évolusi baktéri jeung kaleuleuwihan antibiotik, résistansi S. aureus kana ubar geus ningkat, nyababkeun paningkatan global dina tingkat inféksi MRSA.
According to the sensitivity to antibiotic drugs, S. aureus can be divided into methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA). In recent decades, due to the evolution of bacteria and the abuse of antibiotics, the drug resistance of S. aureus has gradually increased, the infection rate of MRSA has increased worldwide.
 Treatment of severe skin and soft tissue infections: a review 29278528 
NIH
To review the salient features of the management of severe skin and soft tissue infections (SSTIs), including toxic shock syndrome, myonecrosis/gas gangrene, and necrotizing fasciitis.